Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Revance Therapeutics Inc’s stock clocked out at $3.40, up 3.34% from its previous closing price of $3.29. In other words, the price has increased by $3.34 from its previous closing price. On the day, 2.28 million shares were traded. RVNC stock price reached its highest trading level at $3.56 during the session, while it also had its lowest trading level at $3.21.
Ratios:
To gain a deeper understanding of RVNC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.29 and its Current Ratio is at 3.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $16 previously.
On January 09, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $30 to $8.
Exane BNP Paribas Upgraded its Underperform to Neutral on August 16, 2023, while the target price for the stock was maintained at $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 16 ’24 when Jordan Erica sold 2,392 shares for $3.80 per share. The transaction valued at 9,096 led to the insider holds 114,864 shares of the business.
Schilke Tobin sold 9,361 shares of RVNC for $47,204 on Mar 18 ’24. The CFO now owns 192,666 shares after completing the transaction at $5.04 per share. On Mar 18 ’24, another insider, Sjuts Dustin S, who serves as the President of the company, sold 9,211 shares for $5.04 each. As a result, the insider received 46,446 and left with 167,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVNC now has a Market Capitalization of 354334400 and an Enterprise Value of 524446784. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.51. Its current Enterprise Value per Revenue stands at 2.241 whereas that against EBITDA is -2.533.
Stock Price History:
Over the past 52 weeks, RVNC has reached a high of $37.98, while it has fallen to a 52-week low of $3.23. The 50-Day Moving Average of the stock is -32.58%, while the 200-Day Moving Average is calculated to be -66.32%.
Shares Statistics:
It appears that RVNC traded 1.81M shares on average per day over the past three months and 1964430 shares per day over the past ten days. A total of 104.22M shares are outstanding, with a floating share count of 95.22M. Insiders hold about 8.63% of the company’s shares, while institutions hold 75.24% stake in the company. Shares short for RVNC as of 1713139200 were 11625272 with a Short Ratio of 6.41, compared to 1710460800 on 10865757. Therefore, it implies a Short% of Shares Outstanding of 11625272 and a Short% of Float of 12.810000999999998.
